Opthea Limited

Sponsored ADR (1 ADS : 5 Ordinary) International Reporting
OTCQX International OTCQX Advisor: Roth Capital Partners, LLC
Verified Company Profile 9/29/2016
Contact Info
  • Suite 0430 Level 4-650 Chapel Street
  • South Yarra, VIC 3141
  • Australia

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
Audited Financials Audited
Latest Report Jun 30, 2016 Annual Report
CIK 0001519995
Fiscal Year End 6/30
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: Australia
Year of Inc. 1984
Employees 11 a/o Apr 29, 2011
Company Officers/Contacts
Megan Baldwin CEO, Managing Director
Mike Tonroe Secretary, CFO
Company Directors
Russell Howard
Company Notes
  • Formerly=Circadian Technologies Ltd. until 12-2015
Service Providers
OTCQX Advisor
Roth Capital Partners, LLC
888 San Clemente Dr.
Newport Beach, CA, 92660

Accounting/Auditing Firm
Deloitte Touche Tohmatsu
550 Bourke Street
Melbourne, VIC, 3000

Legal Counsel
Not Available
Investor Relations Firm
Not Available
CKDXY Security Details
Share Structure
Market Value1 $33,713,430 a/o Oct 19, 2016
Authorized Shares Unlimited a/o Apr 07, 2011
Outstanding Shares 74,918,733 a/o Oct 10, 2014
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 33,600,000 a/o Dec 31, 2013
Par Value No Par Value
Transfer Agent(s)
BNY Mellon
Shareholders of Record Not Available
Non US Stock Exchange Listing
OPT - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 0 (-100%)
Aug 15, 2012
Significant Failures to Deliver No

1Market Value calculated only for respective security